LICENSED TECHNOLOGY (Details Textual) |
1 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
|
May 26, 2017
USD ($)
|
Jan. 23, 2015
USD ($)
|
Dec. 31, 2017
USD ($)
shares
|
Dec. 31, 2016
USD ($)
|
|
| Other Commitment | $ 231,000 | |||
| Licensed technology | 127,000 | |||
| Amortization of Intangible Assets | $ 534,000 | $ 677,000 | ||
| Abeona Therapeutics LLC [Member] | ||||
| Finite-Lived Intangible Asset, Useful Life | 20 years | |||
| EB Agreement [Member] | ||||
| Number Of License Agreements Research And Development Arrangements | 2 | |||
| Acestor Therapeutics LLC [Member] | ||||
| Equity Method Investment, Ownership Percentage | 80.00% | |||
| License Costs | $ 5,000,000 | |||
| Plasma Technologies, LLC [Member] | ||||
| License Costs | $ 1,000,000 | |||
| Noncontrolling Interest, Ownership Percentage by Parent | 20.00% | |||
| Other Commitment | $ 4,000,000 | |||
| Finite-Lived Intangible Asset, Useful Life | 11 years | |||
| Payable Due Licensor Non current | $ 4,000,000 | |||
| Shares Issued For License Technology Payable | shares | 1,096,151 | |||
| X | ||||||||||
- Definition Amount of licensed technology. No definition available.
|
| X | ||||||||||
- Definition Refers to the number of licensing agreements under research and development arrangements. No definition available.
|
| X | ||||||||||
- Definition Amount less current portion of payable due to licensor. No definition available.
|
| X | ||||||||||
- Definition The number of shares to be issued in the future to settle a payable for licensed technology as of balance sheet date. No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Costs incurred and are directly related to generating license revenue. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. No definition available.
|
| X | ||||||||||
- Definition Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|